CD8A and COVID-19: This is consistent with the observation that mRNA delivery enhances CD8+ T cell priming, as seen with COVID-19 vaccines (42–44), and with MD39.3 mRNA in humans (16), potentially due to antigen synthesis within professional antigen-presenting cells (45).